SOPHiA GENETICS Partners with Jessa Ziekenhuis for Genomic Testing in Belgium
SOPHiA GENETICS has announced a significant collaboration with Jessa Ziekenhuis to advance genomic testing and oncology research in Belgium, announced in a press release. This partnership aims to bring cutting-edge genomic testing to cancer patients across the country.
Jessa Ziekenhuis, a major healthcare institution in Belgium, will integrate SOPHiA DDM™ into its pathology operations. This integration will standardize next-generation sequencing (NGS) workflows, enhancing efficiency and compliance with national guidelines. The hospital will implement six SOPHiA GENETICS applications tailored to its needs in solid tumors, hematologic malignancies, and liquid biopsy analysis.
The collaboration is expected to reduce hands-on time by 30-50%, cut costs by up to 25%, and accelerate testing turnaround times. Additionally, the SOPHiA DDM™ Dispatch feature will allow Jessa Ziekenhuis to share a NovaSeq sequencer with AZ Delta in Roeselare, Belgium, optimizing sequencing capacity and knowledge sharing through the Bridge Consortium.
We hope you enjoyed this article
Consider subscribing to one of our newsletters like Life AI Weekly or Daily AI Brief.
Also, consider following us on social media:
More from Life Sciences
Oct 16 Study Tests Smartphone AI for Children's Lung Sounds Oct 16 Manhattan Physician Invests in RunPractice Oct 16 Attilio appoints Buck Institute CEO Eric Verdin as cochairman Oct 16 Aignostics launches HETA Clinical for pathology workflows Oct 16 Specialty1 Partners Invests in AI for Dental Practice OperationsLife AI Weekly
Weekly coverage of AI applications in healthcare, drug development, biotechnology research, and genomics breakthroughs.
Whitepaper
Tensordyne Napier: What If One Rack Could Do the Work of Nine?
Tensordyne
This Tensordyne whitepaper presents Napier, an inference-focused AI processor and rack-scale system based on the company’s TDN Math logarithmic number system. It examines infrastructure requirements for large mixture-of-experts and agentic models, compares major inference architecture approaches, and details the TDN AIP processor, TDN72 pod, TDN Link fabric, and Napier Ultra configuration. The paper reports simulation-based performance, cost, and accuracy-validation results, including Tensordyne’s projected comparison of one Napier rack with a nine-rack Nvidia Rubin plus Groq deployment; the chip is reported as taped out and in fabrication.
Read moreYou may also like
Domino Data Lab and EPAM Partner on Validated AI for Life Sciences
Suvoda Expands Sofia to All New RTSM and eCOA Trials
Lunit and Discovery Life Sciences Partner on AI Tissue Analysis
Sopris Capital Acquires Blackford Analysis from Bayer
Hansa Biopharma Partners With Cradle on AI Protein Design
Daily AI Brief: the AI news that matters, in your inbox.